The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Prevalence of Diagnosed Atrial Fibrillation in Adults: National Implications for Rhythm Management and Stroke Prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study
Abstract
CONTEXT: Atrial fibrillation is the most common arrhythmia in elderly persons and a potent risk factor for stroke. However, recent prevalence and projected future numbers of persons with atrial fibrillation are not well described. OBJECTIVE: To estimate prevalence of atrial fibrillation and US national projections of the numbers of persons with atrial fibrillation through the year 2050. DESIGN, SETTING, AND PATIENTS: Cross-sectional study of adults aged 20 years or older who were enrolled in a large health maintenance organization in California and who had atrial fibrillation diagnosed between July 1, 1996, and December 31, 1997. MAIN OUTCOME MEASURES: Prevalence of atrial fibrillation in the study population of 1.89 million; projected number of persons in the United States with atrial fibrillation between 1995-2050. RESULTS: A total of 17 974 adults with diagnosed atrial fibrillation were identified during the study period; 45% were aged 75 years or older. The prevalence of atrial fibrillation was 0.95% (95% confidence interval, 0.94%-0.96%). Atrial fibrillation was more common in men than in women (1.1% vs 0.8%; P<.001). Prevalence increased from 0.1% among adults younger than 55 years to 9.0% in persons aged 80 years or older. Among persons aged 50 years or older, prevalence of atrial fibrillation was higher in whites than in blacks (2.2% vs 1.5%; P<.001). We estimate approximately 2.3 million US adults currently have atrial fibrillation. We project that this will increase to more than 5.6 million (lower bound, 5.0; upper bound, 6.3) by the year 2050, with more than 50% of affected individuals aged 80 years or older. CONCLUSIONS: Our study confirms that atrial fibrillation is common among older adults and provides a contemporary basis for estimates of prevalence in the United States. The number of patients with atrial fibrillation is likely to increase 2.5-fold during the next 50 years, reflecting the growing proportion of elderly individuals. Coordinated efforts are needed to face the increasing challenge of optimal stroke prevention and rhythm management in patients with atrial fibrillation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the United States, it is estimated that the number of adults with AF would more than double by the year 2050;16 even higher increases have been predicted.14”
From Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study (2014) · cites this paper as [16]
Citations
Cites
Statistical Methods for Rates and Proportions
Fleiss, J. L., Levin, B., & Paik, M. C. (2003) · Wiley Series in Probability and Statistics · doi:10.1002/0471445428 · Cited by 18,646
Statistical Methods for Rates and Proportions.
Everitt, B. S., & Fleiss, J. L. (1981) · Biometrics · doi:10.2307/2530193 · Cited by 9,034
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
Statistical Methods for Rates and Proportions, 2nd ed
GROVE, W. A. (1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.12.1644-a · Cited by 3,756
Risk Factors for Stroke and Efficacy of Antithrombotic Therapy in Atrial Fibrillation
(1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.13.1449 · Cited by 2,602
Feinberg, W. M. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.5.469 · Cited by 2,282
Incidence of and risk factors for atrial fibrillation in older adults
Psaty, B. M., Manolio, T. A., Kuller, L. H., Kronmal, R. A., Cushman, M., Fried, L. P., White, R., Furberg, C. D., & Rautaharju, P. M. (1997) · Circulation · doi:10.1161/01.cir.96.7.2455 · Cited by 1,462
Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study)
Furberg, C. D., Psaty, B. M., Manolio, T. A., Gardin, J. M., Smith, V. E., & Rautaharju, P. M. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90363-8 · Cited by 1,096
Page, R. L., Wilkinson, W. E., Clair, W. K., McCarthy, E. A., & Pritchett, E. L. (1994) · Circulation · doi:10.1161/01.cir.89.1.224 · Cited by 627
Cited by
Sorted by citations
Items 501–600 of 1,022
Mechanisms of Arrhythmias and Conduction Disorders in Older Adults
Mirza, M., Strunets, A., Shen, W.-K., & Jahangir, A. (2012) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2012.08.005 · Cited by 126
Bell, A., Roussin, A., Cartier, R., Chan, W., Douketis, J. D., Gupta, A. K., Kraw, M. E., Lindsay, T. F., Love, M. P., Pannu, N., et al. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2010.12.015 · Cited by 118
Decker, W. W., Smars, P. A., Vaidyanathan, L., Goyal, D. G., Boie, E. T., Ganti, L., Packer, D. L., Meloy, T. D., Boggust, A. J., Haro, L. H., et al. (2008) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2007.12.015 · Cited by 119
Underweight is a risk factor for atrial fibrillation: A nationwide population-based study
Kang, S., Choi, E., Han, K., Lee, S., Lim, W., Cha, M., Cho, Y., Oh, I., & Oh, S. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.04.036 · Cited by 126
A frameshift deletion in the sarcomere gene MYL4 causes early-onset familial atrial fibrillation
Gudbjartsson, D. F., Hólm, H., Sulem, P., Másson, G., Oddsson, Á., Magnússon, Ó. Þ., Saemundsdottir, J., Helgadottir, H. T., Helgason, H., Johannsdottir, H., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw379 · Cited by 116
Screening for Atrial Fibrillation With Electrocardiography
Jonas, D. E., Kahwati, L. C., Yun, J. D. Y., Middleton, J. C., Coker-Schwimmer, M. J. L., & Asher, G. N. (2018) · JAMA · doi:10.1001/jama.2018.4190 · Cited by 118
The Cost-Effectiveness of Continuous Glucose Monitoring in Type 1 Diabetes
Huang, E. S., O’Grady, M. J., Basu, A., Winn, A. N., John, P. M., Lee, J. M., Meltzer, D. O., Kollman, C., Laffel, L. M., Tamborlane, W. V., et al. (2010) · Diabetes Care · doi:10.2337/dc09-2042 · Cited by 118
Budge, L. P., Shaffer, K. M., Moorman, J. R., Lake, D. E., Ferguson, J., & Mangrum, J. M. (2008) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-008-9281-7 · Cited by 116
Screening for atrial fibrillation in 13 122 Hong Kong citizens with smartphone electrocardiogram
Chan, N.-Y., & Choy, C.-C. (2017) · Heart · doi:10.1136/heartjnl-2016-309993 · Cited by 116
The Expression Levels of Plasma micoRNAs in Atrial Fibrillation Patients
Liu, Z., Zhou, C., Liu, Y., Wang, S., Ye, P., Miao, X., & Xia, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044906 · Cited by 116
Pena, J. M., MacFadyen, J. G., Glynn, R., & Ridker, P. M. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr460 · Cited by 115
Phan, K. H., Xie, A., Meir, M. L., Black, D. A., & Yan, T. D. (2014) · Heart · doi:10.1136/heartjnl-2013-305351 · Cited by 114
Li, G., Sun, H., Zhang, X., Cheng, L., Chiu, S., Tse, H., & Lau, C.-P. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn322 · Cited by 115
Is Atrial Fibrillation a Preventable Disease?
Du, X., Dong, J., & Ma, C. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.02.020 · Cited by 117
Russo, V., Maio, M. D., Attena, E., Silverio, A., Scudiero, F., Celentani, D., Lodigiani, C., & Micco, P. D. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104965 · Cited by 115
Shu, H., Cheng, J. R., Li, N., Zhang, Z., Nie, J., Peng, Y., Wang, Y., Wang, D. W., & Zhou, N. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-01913-5 · Cited by 115
Use of anticoagulants in elderly patients: practical recommendations
Righini, M. (2009) · Clinical Interventions in Aging · doi:10.2147/cia.s4308 · Cited by 114
The Epidemiology of Atrial Fibrillation in Elderly Persons: The Tip of the Iceberg
Go, A. S. (2005) · The American Journal of Geriatric Cardiology · doi:10.1111/j.1076-7460.2005.02278.x · Cited by 114
Self-citationMcGann, C. J., Kholmovski, E. G., Blauer, J. J. E., Vijayakumar, S., Haslam, T. S., Cates, J. E., DiBella, E., Burgon, N. S., Wilson, B. D., Alexander, A., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.04.008 · Cited by 114
Frailty and atrial fibrillation: A systematic review
Villani, E. R., Tummolo, A. M., Palmer, K., Gravina, E. M., Vetrano, D. L., Bernabei, R., Onder, G., & Acampora, N. (2018) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2018.04.018 · Cited by 114
Improved screening for silent atrial fibrillation after ischaemic stroke
Doliwa Sobocinski, P., Anggardh Rooth, E., Frykman Kull, V., von Arbin, M., Wallen, H., & Rosenqvist, M. (2012) · Europace · doi:10.1093/europace/eur431 · Cited by 112
Atrial fibrillation: the role of common and rare genetic variants
Olesen, M. S., Nielsen, M. W., Haunsø, S., & Svendsen, J. H. (2014) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.139 · Cited by 112
Kubitza, D., Becka, M., Roth, A., & Mueck, W. (2013) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.5 · Cited by 116
New onset atrial fibrillation after patent foramen ovale closure
Staubach, S., Steinberg, D. H., Zimmermann, W., Wawra, N., Wilson, N., Wunderlich, N. C., & Sievert, H. (2009) · Catheterization and Cardiovascular Interventions · doi:10.1002/ccd.22172 · Cited by 113
Azarbal, F., Stefanick, M. L., Salmoirago‐Blotcher, E., Manson, J. E., Albert, C. M., LaMonte, M. J., Larson, J. C., Li, W., Martin, L. W., Nassir, R., et al. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001127 · Cited by 113
Goudis, C. A., & Ketikoglou, D. G. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.12.120 · Cited by 116
Cost-Effectiveness of Rhythm versus Rate Control in Atrial Fibrillation
Marshall, D. A., Levy, A. R., Vidaillet, H. J., Jr., Fenwick, E. A. L., Slee, A. E., Blackhouse, G., Greene, H. L., Wyse, D. G., Nichol, G., OʼBrien, B. J., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-9-200411020-00005 · Cited by 112
Lane, D. A., Langman, C. M., Lip, G. Y. H., & Nouwen, A. (2009) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2008.10.007 · Cited by 113
McManus, D. D., Xanthakis, V., Sullivan, L. M., Zachariah, J., Aragam, J., Larson, M. G., Benjamin, E. J., & Vasan, R. S. (2010) · Circulation · doi:10.1161/circulationaha.109.885806 · Cited by 112
The association of human connexin 40 genetic polymorphisms with atrial fibrillation
Juang, J. J., Chern, Y.-R., Tsai, C., Chiang, F., Lin, J.-L., Hwang, J., Hsu, K.-L., Tseng, C.-D., Tseng, Y.-Z., & Lai, L. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.03.037 · Cited by 113
Exercise-based cardiac rehabilitation for adults with atrial fibrillation
Risom, S. S., Zwisler, A., Palm, P., Sibilitz, K. L., Lindschou, J., Gluud, C. N., Taylor, R. S., Svendsen, J. H., & Berg, S. K. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011197.pub2 · Cited by 117
Westerman, S. B., & WENGER, N. K. (2016) · Clinical Science · doi:10.1042/cs20150586 · Cited by 115
Optimal parameters study for sample entropy-based atrial fibrillation organization analysis
Alcaraz, R., Abásolo, D., Hornero, R., & Rieta, J. J. (2010) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2010.02.009 · Cited by 112
Atrial fibrillation, anticoagulation, fall risk, and outcomes in elderly patients
Sellers, M., & Newby, L. K. (2011) · American Heart Journal · doi:10.1016/j.ahj.2010.11.002 · Cited by 111
Atrial Fibrillation Burden in Young Patients With Congenital Heart Disease
Mandalenakis, Z., Rosengren, A., Lappas, G., Eriksson, P., Gilljam, T., Hansson, P., Skoglund, K., Fedchenko, M., & Dellborg, M. (2017) · Circulation · doi:10.1161/circulationaha.117.029590 · Cited by 88
Atrial fibrillation and arterial hypertension
Kallistratos, M. S., Poulimenos, L. E., & Manolis, A. J. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.10.007 · Cited by 114
Burden of Atrial Fibrillation–Associated Ischemic Stroke in the United States
Alkhouli, M. A., Alqahtani, F., Aljohani, S., Alvi, M., & Holmes, D. R. (2018) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2018.02.021 · Cited by 112
Totally Endoscopic Ablation of Lone Atrial Fibrillation: Initial Clinical Experience
Pruitt, J. C., Lazzara, R. R., Dworkin, G. H., Badhwar, V., Kuma, C. R., & Ebra, G. (2006) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2005.07.095 · Cited by 111
Cognitive Function and Anticoagulation Control in Patients With Atrial Fibrillation
Flaker, G. C., Pogue, J. M., Yusuf, S., Pfeffer, M. A., Goldhaber, S. Z., Granger, C. B., Anand, I. S., Hart, R. G., & Connolly, S. J. (2010) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.109.884171 · Cited by 111
Catheter ablation for atrial fibrillation in patients with obesity
Cha, Y.-M., Friedman, P. A., Asirvatham, S. J., Shen, W.-K., Munger, T. M., Rea, R. F., Brady, P. A., Jahangir, A., Monahan, K. H., Hodge, D. O., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.716712 · Cited by 110
Tada, H., Shiffman, D., Smith, J. G., Sjögren, M., Lubitz, S. A., Ellinor, P. T., Louie, J. Z., Catanese, J. J., Engström, G., Devlin, J. J., et al. (2014) · Stroke · doi:10.1161/strokeaha.114.006072 · Cited by 110
Chilukuri, K., Dalal, D., Gadrey, S. M., Marine, J. E., MacPherson, E. C., Henrikson, C. A., Cheng, A., Nazarian, S., Sinha, S. K., SPRAGG, D. D., et al. (2009) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2009.01653.x · Cited by 111
Martínez‐Sellés, M., Roessel, A. M.-V., Garcia, J. A., de la Villa, B. G., Cruz-Jentoft, A. J., Vidán, M. T., López, J., Félix-Redondo, F. J., Guerrero, J. M. D., Bayés‐Genís, A., et al. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.10.034 · Cited by 110
Shared Decision Making in Atrial Fibrillation
Seaburg, L., Hess, E. P., Coylewright, M. J., Ting, H. H., McLeod, C. J., & Montori, V. M. (2014) · Circulation · doi:10.1161/circulationaha.113.004498 · Cited by 109
Ng, K. H., Shestakovska, O., Connolly, S. J., Eikelboom, J. W., Avezum, Á., Díaz, R., Lanas, F. T., Yusuf, S., & Hart, R. G. (2015) · Age and Ageing · doi:10.1093/ageing/afv156 · Cited by 113
Ebrahimzadeh, E., Kalantari, M., Joulani, M., Shahraki, R. S., Fayaz, F., & Ahmadi, F. (2018) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2018.07.014 · Cited by 110
Vernakalant (RSD1235): a novel, atrial-selective antifibrillatory agent
Fedida, D. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.4.519 · Cited by 108
Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK
Ruigómez, A., Johansson, S., Wallander, M.-A. A., & Rodríguez, L. A. G. (2005) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-5-20 · Cited by 110
Are Cost Benefits of Anticoagulation for Stroke Prevention in Atrial Fibrillation Underestimated?
Miller, P. S. J., Andersson, F., & Kalra, L. (2005) · Stroke · doi:10.1161/01.str.0000153002.56324.8c · Cited by 110
Type 2 diabetes mellitus and risk of incident atrial fibrillation in women
Schoen, T., Pradhan, A. D., Albert, C. M., & Conen, D. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.06.030 · Cited by 106
A review of the cost of atrial fibrillation
Wodchis, W. P., Bhatia, R. S., Leblanc, K., Meshkat, N., & Morra, D. (2012) · Value in Health · doi:10.1016/j.jval.2011.09.009 · Cited by 109
Heuzey, J. L., BREITHARDT, G. E., Camm, A. J., Crijns, H. J. G. M., Dorian, P., Kowey, P. R., Merioua, I., Prystowsky, E. N., Schwartz, P. J., Torp-Pedersen, C. T., et al. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.10.012 · Cited by 109
New Therapeutic Targets in Cardiology
Rokita, A. G., & Anderson, M. E. (2012) · Circulation · doi:10.1161/circulationaha.112.124990 · Cited by 117
Pharmacokinetic and Pharmacodynamic Drug Interactions With New Oral Anticoagulants
Hellwig, T. R., & Gulseth, M. P. (2013) · Annals of Pharmacotherapy · doi:10.1177/1060028013504741 · Cited by 109
Health Outcomes With Catheter Ablation or Antiarrhythmic Drug Therapy in Atrial Fibrillation
Reynolds, M. R., Gunnarsson, C., Hunter, T. D., Ladapo, J. A., March, J. L., Zhang, M., & Hao, S. C. (2012) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.111.963108 · Cited by 109
Mörtsell, D., Arbelo, E., Dagres, N., Brugada, J., Laroche, C., Trines, S. A. I. P., Malmborg, H., Höglund, N., Tavazzi, L., Pokushalov, E. A., et al. (2018) · EP Europace · doi:10.1093/europace/euy239 · Cited by 110
Lefebvre, M. D., St‐Onge, M., Glazer‐Cavanagh, M., Bell, L., Nguyen, J. N. K., Nguyen, P. V.-Q., & Tannenbaum, C. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.05.012 · Cited by 112
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion
Meier, B., Blaauw, Y., Khattab, A. A., Lewalter, T., Sievert, H., Tondo, C., & Glikson, M. (2015) · EuroIntervention · doi:10.4244/eijy14m09_18 · Cited by 110
Periprocedural Intracardiac Echocardiography for Left Atrial Appendage Closure
Berti, S. L., Paradossi, U., Meucci, F., Trianni, G., Tzikas, A., Rezzaghi, M., Stolkova, M., Palmieri, C., Mori, F., & Santoro, G. (2014) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2014.04.014 · Cited by 110
Cost-Effectiveness of Genotype-Guided Warfarin Dosing for Patients With Atrial Fibrillation
Patrick, A. R., Avorn, J., & Choudhry, N. K. (2009) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.108.808592 · Cited by 108
Sannino, A., Gargiulo, G., Schiattarella, G. G., Perrino, C., Stabile, E., Losi, M. A., Galderisi, M., Izzo, R., SIMONE, G. D., Trimarco, B., et al. (2016) · EuroIntervention · doi:10.4244/eijy15m11_12 · Cited by 108
Martinez, B. K., Sood, N. A., Bunz, T. J., & Coleman, C. I. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.008643 · Cited by 111
Noubiap, J. J., Tang, J. J., Teraoka, J. T., Dewland, T. A., & Marcus, G. M. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.07.014 · Cited by 108
Resnic, F. S., Robbins, S. L., Denton, J. N., Nookala, L., Meeker, D., Lucila Ohno-machado, A., Matheny, M. E., & FitzHenry, F. (2015) · Applied Clinical Informatics · doi:10.4338/aci-2014-12-cr-0121 · Cited by 108
Sinner, M. F., Pfeufer, A., Akyol, M., Beckmann, B.-M., Hinterseer, M., Wacker, A., Perz, S., Sauter, W., Illig, T., Näbauer, M., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehm619 · Cited by 107
Lee, W. C., Lamas, G. A., Balu, S., Spalding, J. R., Wang, Q., & Pashos, C. L. (2008) · Journal of Medical Economics · doi:10.3111/13696990802063425 · Cited by 108
Efficacy, Safety, and Outcome of Atrial Fibrillation Ablation in Septuagenarians
CORRADO, A., Patel, D., Riedlbauchová, L., Fahmy, T. S. E., Themistoclakis, S., Bonso, A., Rossillo, A., Hao, S. C., Schweikert, R. A., Cummings, J. E., et al. (2008) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01124.x · Cited by 107
Experimental Model of Warfarin-Associated Intracerebral Hemorrhage
Foerch, C., Arai, K., Jin, G., Park, K., Pallast, S., van Leyen, K., & Lo, E. H. (2008) · Stroke · doi:10.1161/strokeaha.108.517482 · Cited by 107
Atrial fibrillation and atrial flutter in athletes
Calvo, N., Brugada, J., Sitges, M., & Mont, L. (2012) · British Journal of Sports Medicine · doi:10.1136/bjsports-2012-091171 · Cited by 110
Jeon, H., Lien, L., Lai, W.-T., Tse, H., Chung, W.-S., Lee, T.-H., Chen, S.-A., & Chung, N. (2010) · Thrombosis and Haemostasis · doi:10.1160/th10-07-0451 · Cited by 107
Atrial Fibrillation, Cognitive Decline and Dementia
Alonso, Á., & Larriva, A. P. A.-D. (2016) · European Cardiology Review · doi:10.15420/ecr.2016:13:2 · Cited by 110
Risk for Incident Atrial Fibrillation in Patients Who Receive Antihypertensive Drugs
Schaer, B. A., Schneider, C., Jick, S. S., Conen, D., Osswald, S., & Meier, C. R. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-2-201001190-00005 · Cited by 107
Sleep-Disordered Breathing and Excessive Daytime Sleepiness in Patients With Atrial Fibrillation
Albuquerque, F. N., Calvin, A. D., Kuniyoshi, F. H. S., Konečný, T., López-Jiménez, F. A., Pressman, G. S., Kara, T., Friedman, P. A., Ammash, N. M., Somers, V. K., et al. (2011) · CHEST Journal · doi:10.1378/chest.11-0975 · Cited by 107
Caffeine consumption and incident atrial fibrillation in women
Conen, D., Chiuve, S. E., Everett, B. M., Zhang, S. M., Buring, J. E., & Albert, C. M. (2010) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.29627 · Cited by 111
Bushnell, C., Culebras, A., DeGraba, T. J., Goldstein, B. A., Adams, R. J., Alberts, M. J., & Appel, L. J. (2006) · Cited by 108
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation
Lafuente‐Lafuente, C., Mouly, S. J., Longás-Tejero, M. A., & Bergmann, J. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005049.pub2 · Cited by 110
Cheng, M., Hu, Z., Lu, X., Huang, J., & Gu, D. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.12.026 · Cited by 106
Anticoagulation in atrial fibrillation
Steinberg, B. A., & Piccini, J. P. (2014) · BMJ · doi:10.1136/bmj.g2116 · Cited by 104
Singer, D. E., Chang, Y., Fang, M. C., Borowsky, L. H., Pomernacki, N. K., Udaltsova, N. V., & Go, A. S. (2009) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.108.830232 · Cited by 106
Self-citationSlot, K. B., & Berge, E. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008980.pub2 · Cited by 109
Huang, H., Liu, Y., Xu, Y., Wang, Z., Li, Y., Cao, K., Zhang, S., Yang, Y., Yang, X., Huang, D., et al. (2017) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2017.06.072 · Cited by 106
Wetmore, J. B., Mahnken, J. D., Rigler, S. K., Ellerbeck, E. F., Mukhopadhyay, P., Spertus, J. A., Hou, Q., & Shireman, T. I. (2011) · Kidney International · doi:10.1038/ki.2011.416 · Cited by 106
The QT interval and risk of incident atrial fibrillation
Mandyam, M. C., Soliman, E. Z., Alonso, Á., Dewland, T. A., Heckbert, S. R., Vittinghoff, E., Cummings, S. R., Ellinor, P. T., CHAITMAN, B. R., Stocke, K. S., et al. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.07.023 · Cited by 105
Cardiac imaging for assessment of left atrial appendage stasis and thrombosis
Romero, J. E., Cao, J. J., Garcia, M. J., & Taub, C. C. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.77 · Cited by 105
Ball, J., Thompson, D. R., Ski, C. F., Carrington, M. J., Gerber, T., & Stewart, S. (2015) · The Medical Journal of Australia · doi:10.5694/mja14.00238 · Cited by 107
Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation
Oldgren, J., Hijazi, Z., Lindbäck, J., Alexander, J. H., Connolly, S. J., Eikelboom, J. W., Ezekowitz, M. D., Granger, C. B., Hylek, E. M., Lópes, R. D., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.022802 · Cited by 107
Self-citationKamaleswaran, R., Mahajan, R., & Akbilgiç, O. (2018) · Physiological Measurement · doi:10.1088/1361-6579/aaaa9d · Cited by 108
Racial Differences in Atrial Fibrillation Prevalence and Left Atrial Size
Marcus, G. M., Olgin, J. E., Whooley, M. A., Vittinghoff, E., Stone, K. L., Mehra, R., Hulley, S. B., & Schiller, N. B. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.05.019 · Cited by 105
Ischaemic stroke subtypes and associated risk factors: a French population based study
Béjot, Y., Caillier, M., Salem, D. B., Couvreur, G., Rouaud, O., Osseby, G.-V., Durier, J., Marie, C., Moreau, T., & Giroud, M. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.150318 · Cited by 106
Polypharmacy and major adverse events in atrial fibrillation: observations from the AFFIRM trial
Proietti, M., Raparelli, V., Olshansky, B., & Lip, G. Y. H. (2015) · Clinical Research in Cardiology · doi:10.1007/s00392-015-0936-y · Cited by 104
Reynolds, M. R., Shah, J. S., Essebag, V., Olshansky, B., Friedman, P. A., Hadjis, T., Lemery, R., Bahnson, T. D., Cannom, D. S., Josephson, M. E., et al. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.09.086 · Cited by 104
Shade, J. K., Ali, R. L., Basile, D., Popescu, D. M., Akhtar, T., Marine, J. E., SPRAGG, D. D., Calkins, H. G., & Trayanova, N. A. (2020) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.119.008213 · Cited by 104
Targeting the apelin system for the treatment of cardiovascular diseases
Chapman, F. A., Maguire, J. J., Newby, D. E., Davenport, A. P., & Dhaun, N. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad171 · Cited by 104
“111 Apelin is involved in regulation of cardiomyocyte electrophysiology, acting on several ion channels to shorten the action potential and increase conduction velocity.”
BackgroundMagee, M. J., Herbert, M. A., Dewey, T. M., Edgerton, J. R., Ryan, W. H., Prince, S. L., & Mack, M. J. (2007) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2006.12.032 · Cited by 104
OLESEN, M. S., Bentzen, B. H., Nielsen, J. B., Steffensen, A. B., David, J., Jabbari, J., Jensen, H. K., Haunsø, S., Svendsen, J. H., & Schmitt, N. (2012) · BMC Medical Genetics · doi:10.1186/1471-2350-13-24 · Cited by 103
Özcan, C., Battaglia, E., Young, R. F., & Suzuki, G. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.114.001733 · Cited by 104
Miyasaka, Y., Barnes, M. E., Gersh, B. J., Cha, S. S., Seward, J. B., Bailey, K. R., Iwasaka, T., & Tsang, T. S. M. (2005) · Stroke · doi:10.1161/01.str.0000185927.63746.23 · Cited by 103
Time-Varying Coherence Function for Atrial Fibrillation Detection
Lee, J., Nam, Y., McManus, D. D., & Chon, K. H. (2013) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2013.2264721 · Cited by 103
Shi, L., Li, C., Wang, C., Xia, Y., Wu, G., Wang, F., Xu, C., Wang, P., Li, X., Wang, D., et al. (2009) · Human Genetics · doi:10.1007/s00439-009-0737-3 · Cited by 104
The impact of height on the risk of atrial fibrillation: the Cardiovascular Health Study
Rosenberg, M. A., Patton, K. K., Sotoodehnia, N., Karas, M. G., Kizer, J. R., ZIMETBAUM, P. J., Chang, J. D., Siscovick, D. S., Gottdiener, J. S., Kronmal, R. A., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs301 · Cited by 102
Metadata
- Authors
- Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E.
- Affiliations
- Kaiser Permanente (US)
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2001-05-09
- Volume
- 285
- Issue
- 18
- Pages
- 2370
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2132505348
- Cited by
- 6,205
- References
- 17
- Citations by year
- 2026: 75 · 2025: 148 · 2024: 193 · 2023: 189 · 2022: 251 · 2021: 263 · 2020: 320 · 2019: 271 · 2018: 323 · 2017: 350 · 2016: 399 · 2015: 437 · 2014: 438 · 2013: 463 · 2012: 424
- FWCI
- 43.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG 15478, R01AG015478)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cardiovascular and Diving-Related Complications
- Keywords
- prevalence, population projections, older adults, sex differences, racial differences, stroke risk, health maintenance organizations, population aging
- MeSH terms
- Adult, Aged, Aged, 80 and over, Atrial Fibrillation, Cross-Sectional Studies, Female, Forecasting, Humans, Male, Middle Aged, United States, Prevalence, Cost of Illness, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review